What do systematic reviews say?

Summary of findings for the main comparison. Physical activity and exercise interventions vs usual care

• Physical activity interventions for people with congenital heart disease 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 18 participants
  Moderate

Summary of findings for the main comparison. Physical activity and exercise interventions vs usual care

• Physical activity interventions for people with congenital heart disease 2020 · Cochrane Headline outcomes only
  no estimate extracted
  11 studies · 501 participants
  Moderate

Summary of findings for the main comparison. Physical activity and exercise interventions vs usual care

The review found no eligible studies for this question.

• Physical activity interventions for people with congenital heart disease 2020 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Home‐based vs centre‐based cardiac rehabilitation

• Home‐based versus centre‐based cardiac rehabilitation 2023 · Cochrane Headline outcomes only
  no estimate extracted
  24 studies · 2343 participants
  Moderate

Home‐based vs centre‐based cardiac rehabilitation

Home‐based showed no clear difference in withdrawal from the exercise programme Number of completers… compared with centre‐based cardiac rehabilitation (low certainty).

• Home‐based versus centre‐based cardiac rehabilitation 2023 · Cochrane Headline outcomes only
  RR 1.04 [0.99, 1.08]
  23 studies · 2638 participants
  Low

Coenzyme Q10 vs placebo or conventional therapy

• Coenzyme Q10 for heart failure 2021 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 91 participants
  Very low

Stem cell therapy vs peripheral therapy with granulocyte colony‐stimulating factor

• Stem cell therapy for dilated cardiomyopathy 2021 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 155 participants
  Low

Usual care with ivabradine vs Placebo, no intervention or usual care (with or without placebo)

• Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 305 participants
  Low
• Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 158 participants
  Low

Usual care with ivabradine vs Placebo, no intervention or usual care (with or without placebo)

• Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 179 participants
  Low
• Ivabradine as adjuvant treatment for chronic heart failure 2020 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 171 participants
  Low

Transmyocardial laser revascularization vs medical treatment

• Transmyocardial laser revascularization versus medical therapy for refractory angina 2015 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 129 participants
  Moderate

Shengmai vs placebo

• Shengmai (a traditional Chinese herbal medicine) for heart failure 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 18 participants
  Low

Shengmai plus usual treatment vs usual treatment alone

• Shengmai (a traditional Chinese herbal medicine) for heart failure 2014 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 60 participants
  Low

Xiongshao capsule (XSC) plus conventional western medicine (CWM) vs Western medicine

Xiongshao capsule (XSC) plus conventional western medicine (CWM) probably leads to lower recurrence angina pectoris Treadmill exercise test compared with conventional western medicine (CWM) (moderate certainty).

• Xiongshao for restenosis after percutaneous coronary intervention in patients with coronary heart disease 2013 · Cochrane Headline outcomes only
  RR 0.47 [0.3, 0.72]
  2 studies · 190 participants
  Moderate

High‐intensity vs moderate‐intensity exercise

• Exercise‐based cardiac rehabilitation in heart transplant recipients 2017 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 16 participants
  Moderate